Review



3168008b 169tm cd25 2a3 fluidigm 3169003b 170er cd45ra hi100 fluidigm 3170010b 171yb cd195 np 6g4 fluidigm 3171017a  (fluidigm)


Bioz Verified Symbol fluidigm is a verified supplier
Bioz Manufacturer Symbol fluidigm manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    fluidigm 3168008b 169tm cd25 2a3 fluidigm 3169003b 170er cd45ra hi100 fluidigm 3170010b 171yb cd195 np 6g4 fluidigm 3171017a
    3168008b 169tm Cd25 2a3 Fluidigm 3169003b 170er Cd45ra Hi100 Fluidigm 3170010b 171yb Cd195 Np 6g4 Fluidigm 3171017a, supplied by fluidigm, used in various techniques. Bioz Stars score: 94/100, based on 16 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/3168008b 169tm cd25 2a3 fluidigm 3169003b 170er cd45ra hi100 fluidigm 3170010b 171yb cd195 np 6g4 fluidigm 3171017a/product/fluidigm
    Average 94 stars, based on 16 article reviews
    3168008b 169tm cd25 2a3 fluidigm 3169003b 170er cd45ra hi100 fluidigm 3170010b 171yb cd195 np 6g4 fluidigm 3171017a - by Bioz Stars, 2026-03
    94/100 stars

    Images



    Similar Products

    94
    fluidigm 3168008b 169tm cd25 2a3 fluidigm 3169003b 170er cd45ra hi100 fluidigm 3170010b 171yb cd195 np 6g4 fluidigm 3171017a
    3168008b 169tm Cd25 2a3 Fluidigm 3169003b 170er Cd45ra Hi100 Fluidigm 3170010b 171yb Cd195 Np 6g4 Fluidigm 3171017a, supplied by fluidigm, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/3168008b 169tm cd25 2a3 fluidigm 3169003b 170er cd45ra hi100 fluidigm 3170010b 171yb cd195 np 6g4 fluidigm 3171017a/product/fluidigm
    Average 94 stars, based on 1 article reviews
    3168008b 169tm cd25 2a3 fluidigm 3169003b 170er cd45ra hi100 fluidigm 3170010b 171yb cd195 np 6g4 fluidigm 3171017a - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    94
    fluidigm 3170007b apc anti mr1 5 op ru tetramer nih tetramer core n a 163dy anti anti apc fluidigm
    3170007b Apc Anti Mr1 5 Op Ru Tetramer Nih Tetramer Core N A 163dy Anti Anti Apc Fluidigm, supplied by fluidigm, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/3170007b apc anti mr1 5 op ru tetramer nih tetramer core n a 163dy anti anti apc fluidigm/product/fluidigm
    Average 94 stars, based on 1 article reviews
    3170007b apc anti mr1 5 op ru tetramer nih tetramer core n a 163dy anti anti apc fluidigm - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    94
    fluidigm 2030 01 170er anti cd3
    2030 01 170er Anti Cd3, supplied by fluidigm, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/2030 01 170er anti cd3/product/fluidigm
    Average 94 stars, based on 1 article reviews
    2030 01 170er anti cd3 - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    93
    fluidigm cd3
    The sequential gating strategy was used to identify immune cell populations from healthy human samples. Healthy donor samples, either ( A ) cryopreserved peripheral blood mononuclear cells (cPBMCs) or ( B ) fresh whole blood (WB), were stimulated for 15 min, fixed, palladium-barcoded, and stained with a comprehensive panel of 19 (for cPBMCs) or 20 (for whole blood) surface markers. Within the single-cell gate, non-granulocytes (leukocytes) were defined as CD66b-CD45 + , while granulocytes were confirmed solely in whole blood as CD66b + CD45-. Lymphocytes were resolved using <t>CD3</t> and CD56 [T cells (CD3 + CD56-)], NKT cells (CD3 + CD56 + ), and NK cells (CD3-CD56 + ). B cells were identified as CD19 + CD20 +/- within the CD3-CD56- gate, further confirmed by negative expression of CD123 and CD11c. Both T and B cells were further subset based on the expression of CD4, CD8, CD45RA, CD27, and CD25 or IgD and CD27, respectively. Non-T, non-B, and non-NK cells (CD45 + CD3-CD19-CD56-CD20-) were separated based on their expression of CD11c and HLA-DR. Total DCs were defined as CD11c + HLA-DR + and can be further defined through the expression of CD123 (plasmacytoid DCs). Monocytes were resolved within this non-lymphocyte gate based on their expression of CD14 and CD16.
    Cd3, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd3/product/fluidigm
    Average 93 stars, based on 1 article reviews
    cd3 - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    fluidigm 3170001b
    The sequential gating strategy was used to identify immune cell populations from healthy human samples. Healthy donor samples, either ( A ) cryopreserved peripheral blood mononuclear cells (cPBMCs) or ( B ) fresh whole blood (WB), were stimulated for 15 min, fixed, palladium-barcoded, and stained with a comprehensive panel of 19 (for cPBMCs) or 20 (for whole blood) surface markers. Within the single-cell gate, non-granulocytes (leukocytes) were defined as CD66b-CD45 + , while granulocytes were confirmed solely in whole blood as CD66b + CD45-. Lymphocytes were resolved using <t>CD3</t> and CD56 [T cells (CD3 + CD56-)], NKT cells (CD3 + CD56 + ), and NK cells (CD3-CD56 + ). B cells were identified as CD19 + CD20 +/- within the CD3-CD56- gate, further confirmed by negative expression of CD123 and CD11c. Both T and B cells were further subset based on the expression of CD4, CD8, CD45RA, CD27, and CD25 or IgD and CD27, respectively. Non-T, non-B, and non-NK cells (CD45 + CD3-CD19-CD56-CD20-) were separated based on their expression of CD11c and HLA-DR. Total DCs were defined as CD11c + HLA-DR + and can be further defined through the expression of CD123 (plasmacytoid DCs). Monocytes were resolved within this non-lymphocyte gate based on their expression of CD14 and CD16.
    3170001b, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/3170001b/product/fluidigm
    Average 93 stars, based on 1 article reviews
    3170001b - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    fluidigm maxpar x8 antibody labeling kit
    The sequential gating strategy was used to identify immune cell populations from healthy human samples. Healthy donor samples, either ( A ) cryopreserved peripheral blood mononuclear cells (cPBMCs) or ( B ) fresh whole blood (WB), were stimulated for 15 min, fixed, palladium-barcoded, and stained with a comprehensive panel of 19 (for cPBMCs) or 20 (for whole blood) surface markers. Within the single-cell gate, non-granulocytes (leukocytes) were defined as CD66b-CD45 + , while granulocytes were confirmed solely in whole blood as CD66b + CD45-. Lymphocytes were resolved using <t>CD3</t> and CD56 [T cells (CD3 + CD56-)], NKT cells (CD3 + CD56 + ), and NK cells (CD3-CD56 + ). B cells were identified as CD19 + CD20 +/- within the CD3-CD56- gate, further confirmed by negative expression of CD123 and CD11c. Both T and B cells were further subset based on the expression of CD4, CD8, CD45RA, CD27, and CD25 or IgD and CD27, respectively. Non-T, non-B, and non-NK cells (CD45 + CD3-CD19-CD56-CD20-) were separated based on their expression of CD11c and HLA-DR. Total DCs were defined as CD11c + HLA-DR + and can be further defined through the expression of CD123 (plasmacytoid DCs). Monocytes were resolved within this non-lymphocyte gate based on their expression of CD14 and CD16.
    Maxpar X8 Antibody Labeling Kit, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/maxpar x8 antibody labeling kit/product/fluidigm
    Average 93 stars, based on 1 article reviews
    maxpar x8 antibody labeling kit - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    fluidigm 170er
    The sequential gating strategy was used to identify immune cell populations from healthy human samples. Healthy donor samples, either ( A ) cryopreserved peripheral blood mononuclear cells (cPBMCs) or ( B ) fresh whole blood (WB), were stimulated for 15 min, fixed, palladium-barcoded, and stained with a comprehensive panel of 19 (for cPBMCs) or 20 (for whole blood) surface markers. Within the single-cell gate, non-granulocytes (leukocytes) were defined as CD66b-CD45 + , while granulocytes were confirmed solely in whole blood as CD66b + CD45-. Lymphocytes were resolved using <t>CD3</t> and CD56 [T cells (CD3 + CD56-)], NKT cells (CD3 + CD56 + ), and NK cells (CD3-CD56 + ). B cells were identified as CD19 + CD20 +/- within the CD3-CD56- gate, further confirmed by negative expression of CD123 and CD11c. Both T and B cells were further subset based on the expression of CD4, CD8, CD45RA, CD27, and CD25 or IgD and CD27, respectively. Non-T, non-B, and non-NK cells (CD45 + CD3-CD19-CD56-CD20-) were separated based on their expression of CD11c and HLA-DR. Total DCs were defined as CD11c + HLA-DR + and can be further defined through the expression of CD123 (plasmacytoid DCs). Monocytes were resolved within this non-lymphocyte gate based on their expression of CD14 and CD16.
    170er, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/170er/product/fluidigm
    Average 93 stars, based on 1 article reviews
    170er - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    fluidigm 201170a
    The sequential gating strategy was used to identify immune cell populations from healthy human samples. Healthy donor samples, either ( A ) cryopreserved peripheral blood mononuclear cells (cPBMCs) or ( B ) fresh whole blood (WB), were stimulated for 15 min, fixed, palladium-barcoded, and stained with a comprehensive panel of 19 (for cPBMCs) or 20 (for whole blood) surface markers. Within the single-cell gate, non-granulocytes (leukocytes) were defined as CD66b-CD45 + , while granulocytes were confirmed solely in whole blood as CD66b + CD45-. Lymphocytes were resolved using <t>CD3</t> and CD56 [T cells (CD3 + CD56-)], NKT cells (CD3 + CD56 + ), and NK cells (CD3-CD56 + ). B cells were identified as CD19 + CD20 +/- within the CD3-CD56- gate, further confirmed by negative expression of CD123 and CD11c. Both T and B cells were further subset based on the expression of CD4, CD8, CD45RA, CD27, and CD25 or IgD and CD27, respectively. Non-T, non-B, and non-NK cells (CD45 + CD3-CD19-CD56-CD20-) were separated based on their expression of CD11c and HLA-DR. Total DCs were defined as CD11c + HLA-DR + and can be further defined through the expression of CD123 (plasmacytoid DCs). Monocytes were resolved within this non-lymphocyte gate based on their expression of CD14 and CD16.
    201170a, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/201170a/product/fluidigm
    Average 93 stars, based on 1 article reviews
    201170a - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    Image Search Results


    The sequential gating strategy was used to identify immune cell populations from healthy human samples. Healthy donor samples, either ( A ) cryopreserved peripheral blood mononuclear cells (cPBMCs) or ( B ) fresh whole blood (WB), were stimulated for 15 min, fixed, palladium-barcoded, and stained with a comprehensive panel of 19 (for cPBMCs) or 20 (for whole blood) surface markers. Within the single-cell gate, non-granulocytes (leukocytes) were defined as CD66b-CD45 + , while granulocytes were confirmed solely in whole blood as CD66b + CD45-. Lymphocytes were resolved using CD3 and CD56 [T cells (CD3 + CD56-)], NKT cells (CD3 + CD56 + ), and NK cells (CD3-CD56 + ). B cells were identified as CD19 + CD20 +/- within the CD3-CD56- gate, further confirmed by negative expression of CD123 and CD11c. Both T and B cells were further subset based on the expression of CD4, CD8, CD45RA, CD27, and CD25 or IgD and CD27, respectively. Non-T, non-B, and non-NK cells (CD45 + CD3-CD19-CD56-CD20-) were separated based on their expression of CD11c and HLA-DR. Total DCs were defined as CD11c + HLA-DR + and can be further defined through the expression of CD123 (plasmacytoid DCs). Monocytes were resolved within this non-lymphocyte gate based on their expression of CD14 and CD16.

    Journal: Bio-protocol

    Article Title: Dual Phospho-CyTOF Workflows for Comparative JAK/STAT Signaling Analysis in Human Cryopreserved PBMCs and Whole Blood

    doi: 10.21769/BioProtoc.5512

    Figure Lengend Snippet: The sequential gating strategy was used to identify immune cell populations from healthy human samples. Healthy donor samples, either ( A ) cryopreserved peripheral blood mononuclear cells (cPBMCs) or ( B ) fresh whole blood (WB), were stimulated for 15 min, fixed, palladium-barcoded, and stained with a comprehensive panel of 19 (for cPBMCs) or 20 (for whole blood) surface markers. Within the single-cell gate, non-granulocytes (leukocytes) were defined as CD66b-CD45 + , while granulocytes were confirmed solely in whole blood as CD66b + CD45-. Lymphocytes were resolved using CD3 and CD56 [T cells (CD3 + CD56-)], NKT cells (CD3 + CD56 + ), and NK cells (CD3-CD56 + ). B cells were identified as CD19 + CD20 +/- within the CD3-CD56- gate, further confirmed by negative expression of CD123 and CD11c. Both T and B cells were further subset based on the expression of CD4, CD8, CD45RA, CD27, and CD25 or IgD and CD27, respectively. Non-T, non-B, and non-NK cells (CD45 + CD3-CD19-CD56-CD20-) were separated based on their expression of CD11c and HLA-DR. Total DCs were defined as CD11c + HLA-DR + and can be further defined through the expression of CD123 (plasmacytoid DCs). Monocytes were resolved within this non-lymphocyte gate based on their expression of CD14 and CD16.

    Article Snippet: 170 Er , CD3 , Standard BioTools , 3170001B , UCHT1 , 17.5.

    Techniques: Staining, Expressing

    This bar graph illustrates the average frequency of total (%) of the major immune cell subsets in donor-matched ( A ) cPBMCs and ( B ) whole blood from (n = 3) healthy individuals. The data points represent the average frequency of total (%) of each subset, with error bars indicating the standard deviation from triplicate samples. Major immune subsets, including B cells, monocytes, dendritic cells (DCs), NK cells, NKT cells, and T cells, were identified using a comprehensive high-dimensional immunophenotyping strategy defined after Gaussian parameter cleanup (Figure 2) and doublet exclusion. These lineages were identified through expression of markers such as CD3, CD19, CD56, CD14, CD11c, HLA-DR, and CD66b, following the detailed gating strategy outlined in Figure 3. As expected, cPBMCs have a higher proportional representation of lymphocytes (T cells, B cells, NK, and NKT cells) and monocytes but lack granulocytes, whereas whole blood maintains the complete cellular repertoire, including a larger proportion of granulocytes and what appears to be a lower percentage of lymphocyte or monocyte subsets due to being expressed as a percentage of total leukocytes.

    Journal: Bio-protocol

    Article Title: Dual Phospho-CyTOF Workflows for Comparative JAK/STAT Signaling Analysis in Human Cryopreserved PBMCs and Whole Blood

    doi: 10.21769/BioProtoc.5512

    Figure Lengend Snippet: This bar graph illustrates the average frequency of total (%) of the major immune cell subsets in donor-matched ( A ) cPBMCs and ( B ) whole blood from (n = 3) healthy individuals. The data points represent the average frequency of total (%) of each subset, with error bars indicating the standard deviation from triplicate samples. Major immune subsets, including B cells, monocytes, dendritic cells (DCs), NK cells, NKT cells, and T cells, were identified using a comprehensive high-dimensional immunophenotyping strategy defined after Gaussian parameter cleanup (Figure 2) and doublet exclusion. These lineages were identified through expression of markers such as CD3, CD19, CD56, CD14, CD11c, HLA-DR, and CD66b, following the detailed gating strategy outlined in Figure 3. As expected, cPBMCs have a higher proportional representation of lymphocytes (T cells, B cells, NK, and NKT cells) and monocytes but lack granulocytes, whereas whole blood maintains the complete cellular repertoire, including a larger proportion of granulocytes and what appears to be a lower percentage of lymphocyte or monocyte subsets due to being expressed as a percentage of total leukocytes.

    Article Snippet: 170 Er , CD3 , Standard BioTools , 3170001B , UCHT1 , 17.5.

    Techniques: Standard Deviation, Expressing